These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35354191)
1. Distinguishing between Neuroleptic Malignant Syndrome and Serotonin Syndrome in Polypharmacy: An Overview with a Case Report. Debeljak T; Kores Plesničar B Psychiatr Danub; 2021; 33(Suppl 4):1227-1229. PubMed ID: 35354191 [No Abstract] [Full Text] [Related]
2. A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy. Ott M; Werneke U Pediatr Emerg Care; 2019 May; 35(5):e98. PubMed ID: 30964850 [No Abstract] [Full Text] [Related]
4. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. Dosi R; Ambaliya A; Joshi H; Patell R BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957740 [TBL] [Abstract][Full Text] [Related]
5. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Perry PJ; Wilborn CA Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571 [TBL] [Abstract][Full Text] [Related]
6. A diagnostic confusion between Serotonin syndrome and Neuroleptic malignant syndrome. Prakash S Am J Emerg Med; 2021 May; 43():272-273. PubMed ID: 33008703 [No Abstract] [Full Text] [Related]
7. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. Sanaei-Zadeh H Ann Pharmacother; 2012 Apr; 46(4):612; author reply 613. PubMed ID: 22414792 [No Abstract] [Full Text] [Related]
8. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. Darracq MA Ann Pharmacother; 2012 Apr; 46(4):611-2; author reply 613. PubMed ID: 22414789 [No Abstract] [Full Text] [Related]
10. The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. Soh M; Hifumi T; Isokawa S; Shimizu M; Otani N; Ishimatsu S Am J Emerg Med; 2021 May; 43():274. PubMed ID: 32622686 [No Abstract] [Full Text] [Related]
11. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. Sokoro AA; Zivot J; Ariano RE Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660 [TBL] [Abstract][Full Text] [Related]
12. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist? Prakash S; Lodha D; Rawat KS BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400419 [TBL] [Abstract][Full Text] [Related]
13. Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome. Brantley E; Cohn J; Babu K J Med Toxicol; 2009 Jun; 5(2):92-8. PubMed ID: 19415596 [No Abstract] [Full Text] [Related]
14. Neuroleptic malignant syndrome during multiple antipsychotic therapy. McDermott M; Noordsy DL; Traum M Community Ment Health J; 2013 Feb; 49(1):45-6. PubMed ID: 22038421 [No Abstract] [Full Text] [Related]
15. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? Odagaki Y Curr Drug Saf; 2009 Jan; 4(1):84-93. PubMed ID: 19149529 [TBL] [Abstract][Full Text] [Related]
16. A Mixed Presentation of Serotonin Syndrome vs Neuroleptic Malignant Syndrome in a 12-Year-Old Boy. Sun C; Sweet H; Minns AB; Shapiro D; Jenkins W Pediatr Emerg Care; 2020 Oct; 36(10):e589-e591. PubMed ID: 29698346 [TBL] [Abstract][Full Text] [Related]